- Home
- Publications
- Publication Search
- Publication Details
Title
SMYD3: a regulator of epigenetic and signaling pathways in cancer
Authors
Keywords
-
Journal
Clinical Epigenetics
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-27
DOI
10.1186/s13148-021-01021-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High expression of SMYD3 indicates poor survival outcome and promotes tumour progression through an IGF-1R/AKT/E2F-1 positive feedback loop in bladder cancer
- (2020) Guoliang Wang et al. Aging-US
- SMYD3: An Oncogenic Driver Targeting Epigenetic Regulation and Signaling Pathways
- (2020) Cinzia Bottino et al. Cancers
- SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in non‑small cell lung cancer
- (2020) Jing Li et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma
- (2019) Zhenyu Zhou et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Expression patterns and the prognostic value of the SMYD family members in human breast carcinoma using integrative bioinformatics analysis
- (2019) Jianping Song et al. Oncology Letters
- Amplification of SMYD3 promotes tumorigenicity and intrahepatic metastasis of hepatocellular carcinoma via upregulation of CDK2 and MMP2
- (2019) Yu Wang et al. ONCOGENE
- SMYD3 promotes epithelial ovarian cancer metastasis by downregulating p53 protein stability and promoting p53 ubiquitination
- (2019) Liwei Zhang et al. CARCINOGENESIS
- Small-molecule inhibitors of lysine methyltransferases SMYD2 and SMYD3: current trends
- (2019) Edoardo Fabini et al. Future Medicinal Chemistry
- Discovery of Irreversible Inhibitors Targeting Histone Methyltransferase, SMYD3
- (2019) Chuhui Huang et al. ACS Medicinal Chemistry Letters
- A Novel lncRNA IHS Promotes Tumor Proliferation and Metastasis in HCC by Regulating the ERK- and AKT/GSK-3β-Signaling Pathways
- (2019) Zheng Chen et al. Molecular Therapy-Nucleic Acids
- Overexpression of the SMYD3 Promotes Proliferation, Migration, and Invasion of Pancreatic Cancer
- (2019) Cheng-lin Zhu et al. DIGESTIVE DISEASES AND SCIENCES
- SMYD3 promotes implant metastasis of ovarian cancer via H3K4 trimethylation of integrin promoters
- (2019) Tianjiao Lyu et al. INTERNATIONAL JOURNAL OF CANCER
- Effect of SMYD3 on biological behavior and H3K4 methylation in bladder cancer
- (2019) Xiang Wu et al. Cancer Management and Research
- The SMYD3 methyltransferase promotes myogenesis by activating the myogenin regulatory network
- (2019) Roberta Codato et al. Scientific Reports
- Exploration of the Substrate Preference of Lysine Methyltransferase SMYD3 by Molecular Dynamics Simulations
- (2019) Jixue Sun et al. ACS Omega
- SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance
- (2018) Tao Wang et al. CANCER LETTERS
- SMYD3 promoter hypomethylation is associated with the risk of colorectal cancer
- (2018) Bin Li et al. Future Oncology
- High immunoexpression of Ki67, EZH2, and SMYD3 in diagnostic prostate biopsies independently predicts outcome in patients with prostate cancer
- (2018) João Lobo et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- SMYD3 promotes the epithelial–mesenchymal transition in breast cancer
- (2018) Claudio Fenizia et al. NUCLEIC ACIDS RESEARCH
- The interaction of lncRNA EZR-AS1 with SMYD3 maintains overexpression of EZR in ESCC cells
- (2017) Xiao-Dan Zhang et al. NUCLEIC ACIDS RESEARCH
- Smyd3-associated regulatory pathways in cancer
- (2017) Antonis Giakountis et al. SEMINARS IN CANCER BIOLOGY
- Protein lysine methyltransferase SMYD3 is involved in tumorigenesis through regulation of HER2 homodimerization
- (2017) Yuichiro Yoshioka et al. Cancer Medicine
- ATM Signaling Pathway Is Implicated in the SMYD3-mediated Proliferation and Migration of Gastric Cancer Cells
- (2017) Lei Wang et al. Journal of Gastric Cancer
- Smyd3 Is a Transcriptional Potentiator of Multiple Cancer-Promoting Genes and Required for Liver and Colon Cancer Development
- (2016) Michalis E. Sarris et al. CANCER CELL
- SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma
- (2016) Ying Zhu et al. HUMAN PATHOLOGY
- Interaction of the hepatitis B virus X protein with the lysine methyltransferase SET and MYND domain-containing 3 induces activator protein 1 activation
- (2016) Miwako Hayashi et al. MICROBIOLOGY AND IMMUNOLOGY
- SMYD3-mediated lysine methylation in the PH domain is critical for activation of AKT1
- (2016) Yuichiro Yoshioka et al. Oncotarget
- SET and MYND domain-containing protein 3 is overexpressed in human glioma and contributes to tumorigenicity
- (2015) BIN DAI et al. ONCOLOGY REPORTS
- Upregulated SMYD3 promotes bladder cancer progression by targeting BCLAF1 and activating autophagy
- (2015) Bing Shen et al. TUMOR BIOLOGY
- SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3
- (2015) Filipa Quintela Vieira et al. Oncotarget
- C-terminal domain of SMYD3 serves as a unique HSP90-regulated motif in oncogenesis
- (2015) Mark A. Brown et al. Oncotarget
- Overexpression of SMYD3 was associated with increased STAT3 activation in gastric cancer
- (2014) Yong Liu et al. MEDICAL ONCOLOGY
- A draft map of the human proteome
- (2014) Min-Sik Kim et al. NATURE
- SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer
- (2014) Pawel K. Mazur et al. NATURE
- Effect of the downregulation of SMYD3 expression by RNAi on RIZ1 expression and proliferation of esophageal squamous cell carcinoma
- (2014) SHANG-WEN DONG et al. ONCOLOGY REPORTS
- SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma
- (2014) Yong Liu et al. TUMOR BIOLOGY
- Control of Autophagic Cell Death by Caspase-10 in Multiple Myeloma
- (2013) Laurence Lamy et al. CANCER CELL
- The methyltransferase SMYD3 mediates the recruitment of transcriptional cofactors at the myostatin and c-Met genes and regulates skeletal muscle atrophy
- (2013) V. Proserpio et al. GENES & DEVELOPMENT
- SMYD3 as an Oncogenic Driver in Prostate Cancer by Stimulation of Androgen Receptor Transcription
- (2013) Cheng Liu et al. JNCI-Journal of the National Cancer Institute
- Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylation
- (2012) Glenn S. Van Aller et al. Epigenetics
- Integrated genomic analyses identify WEE1 as a critical mediator of cell fate and a novel therapeutic target in acute myeloid leukemia
- (2012) C C Porter et al. LEUKEMIA
- Biochemical Characterization of Human SET and MYND Domain-Containing Protein 2 Methyltransferase
- (2011) Jiaquan Wu et al. BIOCHEMISTRY
- Knockdown of SMYD3 by RNA interference inhibits cervical carcinoma cell growth and invasion in vitro
- (2011) Shu-zhen Wang et al. BMB Reports
- Increased androgen receptor transcription: a cause of castration-resistant prostate cancer and a possible therapeutic target
- (2011) Masaki Shiota et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Crystal Structures of Histone and p53 Methyltransferase SmyD2 Reveal a Conformational Flexibility of the Autoinhibitory C-Terminal Domain
- (2011) Yuanyuan Jiang et al. PLoS One
- Structural and Functional Profiling of the Human Histone Methyltransferase SMYD3
- (2011) Kenneth W. Foreman et al. PLoS One
- Smyd3 Is Required for the Development of Cardiac and Skeletal Muscle in Zebrafish
- (2011) Tomoaki Fujii et al. PLoS One
- Multiplexed Quantum Dot Labeling of Activated c-Met Signaling in Castration-Resistant Human Prostate Cancer
- (2011) Peizhen Hu et al. PLoS One
- The Insulin-Like Growth Factor Receptor I Promotes Motility and Invasion of Bladder Cancer Cells through Akt- and Mitogen-Activated Protein Kinase-Dependent Activation of Paxillin
- (2010) David Metalli et al. AMERICAN JOURNAL OF PATHOLOGY
- Crystal Structure of Cardiac-specific Histone Methyltransferase SmyD1 Reveals Unusual Active Site Architecture
- (2010) Nualpun Sirinupong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structural Insights into the Autoinhibition and Posttranslational Activation of Histone Methyltransferase SmyD3
- (2010) Nualpun Sirinupong et al. JOURNAL OF MOLECULAR BIOLOGY
- Effects of SMYD3 over-expression on cell cycle acceleration and cell proliferation in MDA-MB-231 human breast cancer cells
- (2010) Tian-nian Ren et al. MEDICAL ONCOLOGY
- STAT-3 correlates with lymph node metastasis and cell survival in gastric cancer
- (2010) Jing-Yu Deng WORLD JOURNAL OF GASTROENTEROLOGY
- Knockdown of SMYD3 by RNA interference down-regulates c-Met expression and inhibits cells migration and invasion induced by HGF
- (2009) Jia-Ning Zou et al. CANCER LETTERS
- Requirement of Histone Methyltransferase SMYD3 for Estrogen Receptor-mediated Transcription
- (2009) Hyunjung Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Protein phosphatase 2A regulatory subunits and cancer
- (2008) Pieter J.A. Eichhorn et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Association of the variable number of tandem repeats polymorphism in the promoter region of the SMYD3 gene with risk of esophageal squamous cell carcinoma in relation to tobacco smoking
- (2008) Haijian Wang et al. CANCER SCIENCE
- Hepatitis B virus X protein upregulates expression of SMYD3 and C-MYC in HepG2 cells
- (2008) Lian Yang et al. MEDICAL ONCOLOGY
- p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation
- (2008) Hongwu Zheng et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started